Clinical characteristics and resource utilization of 19,130 hospitalizations of patients with ankylosing spondylitis in United States: National Inpatient Sample 2018 - 08/05/22
Doi : 10.1016/j.jbspin.2021.105313
Patompong Ungprasert a, ⁎ 
, Thanat Chaikijurajai b, c, Karn Wijarnpreecha d, Paul T. Kröner d
, Thanat Chaikijurajai b, c, Karn Wijarnpreecha d, Paul T. Kröner d a Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA
b Internal Medicine Residency Program, University of Minnesota Medical School, Minneapolis, MN, USA
c Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
d Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Jacksonville, FL, USA
⁎Corresponding author.
Highlights |
• | Inpatient prevalence of AS was 53.9 cases per 100,000 admissions. |
• | Infection and arthroplasty were the most common reasons for admission. |
• | Admission for patients with AS was associated with a higher expenditure. |
Keywords : Polymyositis, Dermatomyositis, Epidemiology, Hospitalization, Expenditures
Plan
© 2021
Société française de rhumatologie. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 89 - N° 3
Article 105313- mai 2022 Retour au numéro
Article précédent
- Nora's lesion
- Cyrielle Genicon, Frédéric Rongieras, François Le Moigne
- Galectin 9, CXCL-10 and tumor necrosis factor receptor type II as biomarkers of disease activity in systemic lupus erythematosus
- Noémie Gensous, Damien Vagner, Thomas Barnetche, Pierre Duffau, Estibaliz Lazaro, Christophe Richez, Patrick Blanco
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?